TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment

<div>Association with TREM2 expression and clinicopathological characteristics. (a) There was a statistically significant difference between TREM2 mRNA levels and BMI. (b–f) There was no statistically significant difference between TREM2 mRNA levels and age, gender, and pathologic T, N, and M stage.</div>

Disease Markers

fig2

Figure 2

Figure 2: TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment 